ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 50 filers reported holding ATYR PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,757 | -96.9% | 8,565 | -95.7% | 0.00% | -100.0% |
| Q3 2022 | $604,000 | -43.0% | 201,361 | -46.2% | 0.00% | -33.3% |
| Q2 2022 | $1,060,000 | -68.3% | 374,395 | -40.1% | 0.01% | -68.4% |
| Q1 2022 | $3,344,000 | -28.4% | 625,000 | 0.0% | 0.02% | -17.4% |
| Q4 2021 | $4,669,000 | -17.7% | 625,000 | 0.0% | 0.02% | -8.0% |
| Q3 2021 | $5,675,000 | – | 625,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tikvah Management LLC | 1,225,833 | $9,157,000 | 2.55% |
| Stonepine Capital Management, LLC | 525,531 | $3,926,000 | 1.80% |
| Telemetry Investments, L.L.C. | 176,782 | $1,321,000 | 1.70% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $8,317,000 | 1.67% |
| VR Adviser, LLC | 1,565,000 | $11,691,000 | 1.60% |
| Deep Track Capital, LP | 1,100,000 | $8,217,000 | 0.58% |
| EAM Investors, LLC | 252,280 | $1,885,000 | 0.31% |
| EAM Global Investors LLC | 152,792 | $1,141,000 | 0.20% |
| FEDERATED HERMES, INC. | 5,222,250 | $39,010,000 | 0.07% |
| Alyeska Investment Group, L.P. | 674,975 | $5,042,000 | 0.06% |